CiteSpace-based visual analysis of the impact of weight loss on the cardiovascular system in the past 20 years

doi:10.3877/cma.j.issn.2095-9605.2023.04.003

Abstract

Abstract:

Objective

To retrieve relevant literature on weight reduction in the cardiovascular field from 2003 to 2022 and explore the international research hotspots and development trends in this field.

Methods

Relevant literature was retrieved from the Web of Science (WOS), and the annual publication volume was analyzed. Visual analysis of countries, institutions, authors, and keywords was conducted using the CiteSpace tool.

Results

3946 articles were obtained from 799 authors affiliated with 514 research institutions in 106 countries. The publication volume showed an increasing trend, with the United States having the highest publication volume and China ranking sixth. Harvard University had the highest publication volume among research institutions, and there was some collaboration between various institutions. Professor Lavie Carl J from the Mayo Clinic in the United States had the highest output in this research field. There was close collaboration among research authors as a team. The Peking Union Medical College had the highest publication volume among Chinese research institutions but still lagged internationally. Keyword analysis indicated that research on weight reduction in the cardiovascular field primarily focused on the effects and mechanisms of exercise and bariatric surgery on cardiovascular diseases such as heart failure, coronary heart disease, and atrial fibrillation.

Conclusions

Research on weight reduction in the cardiovascular field is receiving increasing attention, and the preventive and therapeutic effects of weight reduction on cardiovascular diseases have been confirmed in numerous studies. However, the controversy surrounding the "obesity paradox" requires further exploration of the relevant practices and mechanisms of weight reduction and cardiovascular benefits.

Key words: Weight reduction, Cardiovascular system, Visual analysis, CiteSpace

Ronggang Peng, Fang Yang, Qian Liu, Yajuan Yang, Qing Zhao. CiteSpace-based visual analysis of the impact of weight loss on the cardiovascular system in the past 20 years[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2023, 09(04): 237-245.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfpydxbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9605.2023.04.003

https://zhfpydxbdzzz.cma-cmc.com.cn/EN/Y2023/V09/I04/237

Figures/Tables 10

References 41

[1]	Chen K, Shen Z, Gu W, et al. Prevalence of obesity and associated complications in China: A cross-sectional, real-world study in 15.8 million adults [J]. Diabetes, obesity & metabolism, 2023, 25(11): 3390-3399.
[2]	中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2022概要[J]. 中国循环杂志, 2023, 38(06): 583-612.
[3]	Larsson SC, Bäck M, Rees JMB, et al. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study [J]. Eur Heart J, 2020, 41(2): 221-226.
[4]	Fekri N, Khaloo P, Ramezankhani A, et al. Association of body mass index with life expectancy with and without cardiovascular disease [J]. International journal of obesity (2005), 2020, 44(1): 195-203.
[5]	Zhao Y, Yu B Y, Liu Y, et al. Weight reduction and cardiovascular benefits: Protocol for a systematic review and meta-analysis [J]. Medicine, 2018, 97(50): e13246.
[6]	中华医学会心血管病学分会，中国康复医学会心脏预防与康复专业委员会，中国老年学和老年医学会心脏专业委员会等. 中国心血管病一级预防指南 [J]. 中华心血管病杂志, 2020, 48(12): 1000-1038.
[7]	Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice [J]. Eur Heart J, 2021, 42(34): 3227-3337.
[8]	Simati S, Kokkinos A, Dalamaga M, et al. Obesity Paradox: Fact or Fiction? [J]. Curr Obes Rep, 2023, 12(2): 75-85.
[9]	Chen C, Chen Y, Hou J, et al. CiteSpace Ⅱ: Detecting and Visualizing Emerging Trends and Transient Patterns in Scientific Literature [J]. Journal of the China Society for Scientific and Technical Information, 2009, 28(3): 401-421.
[10]	姚雪, 徐川平, 李杰, 等. 基于普赖斯定律和二八定律及在线投稿系统构建某科技期刊核心作者用户库 [J]. 编辑学报, 2017, 29(1): 64-66.
[11]	Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism [J]. Circulation, 2006, 113(6): 898-918.
[12]	Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society [J]. Circulation, 2014, 129(25 Suppl 2): S102-138.
[13]	Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [J]. Circulation, 2019, 140(11): e563-e595.
[14]	Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association [J]. Circulation, 2021, 143(21): e984-e1010.
[15]	赵宁, 王宇, 王清波, 等. 过去10年我国减重代谢手术的研究进展 [J/CD ]. 中华肥胖与代谢病电子杂志, 2019, 5(3): 123-127.
[16]	Roth GA, Johnson C, Abajobir A, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 [J]. J Am Coll Cardiol, 2017, 70(1): 1-25.
[17]	Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss [J]. J Am Coll Cardiol, 2009, 53(21): 1925-1932.
[18]	Lavie CJ, Ross R, Neeland IJ. Physical activity and fitness vs adiposity and weight loss for the prevention of cardiovascular disease and cancer mortality [J]. Int J Obes (Lond), 2022, 46(12): 2065-2067.
[19]	Doehner W, Gerstein HC, Ried J, et al. Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial [J]. Eur Heart J, 2020, 41(28): 2668-2677.
[20]	Semlitsch T, Stigler FL, Jeitler K, et al. Management of overweight and obesity in primary care-A systematic overview of international evidence-based guidelines [J]. Obes Rev, 2019, 20(9): 1218-1230.
[21]	Bray G A, Frühbeck G, Ryan D H, et al. Management of obesity [J]. Lancet, 2016, 387(10031): 1947-1956.
[22]	Celik O, Yildiz BO. Obesity and physical exercise [J]. Minerva Endocrinol (Torino), 2021, 46(2): 131-144.
[23]	Oppert JM, Bellicha A, van Baak MA, et al. Exercise training in the management of overweight and obesity in adults: Synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group [J]. Obes Rev, 2021, 22 Suppl 4(Suppl 4): e13273.
[24]	Shi Q, Wang Y, Hao Q, et al. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials [J]. Lancet, 2022, 399(10321): 259-269.
[25]	Neeland IJ, McGuire DK, Sattar N. Cardiovascular Outcomes Trials for Weight Loss Interventions: Another Tool for Cardiovascular Prevention? [J]. Circulation, 2021, 144(17): 1359-1361.
[26]	Jensen SBK, Janus C, Lundgren JR, et al. Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment [J]. Nat Commun, 2022, 13(1): 4770.
[27]	van Rijswijk AS, van Olst N, Schats W, et al. What Is Weight Loss After Bariatric Surgery Expressed in Percentage Total Weight Loss (%TWL)? A Systematic Review [J]. Obes Surg, 2021, 31(8): 3833-3847.
[28]	O'Brien PE, Hindle A, Brennan L, et al. Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding [J]. Obes Surg, 2019, 29(1): 3-14.
[29]	Chi M, Nie Y, Su Y, et al. Effects of weight loss in heart failure patients with overweight and obesity: a systematic review and meta-analysis [J]. Eur J Prev Cardiol, 2023.
[30]	Sundström J, Bruze G, Ottosson J, et al. Weight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment[J]. Circulation, 2017, 135(17): 1577-1585.
[31]	Chandrakumar H, Khatun N, Gupta T, et al. The Effects of Bariatric Surgery on Cardiovascular Outcomes and Cardiovascular Mortality: A Systematic Review and Meta-Analysis [J]. Cureus, 2023, 15(2): e34723.
[32]	Fantin F, Giani A, Zoico E, et al. Weight Loss and Hypertension in Obese Subjects [J]. Nutrients, 2019, 11(7): 1667.
[33]	王滢莹, 秦俭, 程丽芳. 肥胖悖论与心血管疾病 [J]. 心血管病学进展, 2022, 43(1): 52-55.
[34]	Tutor AW, Lavie CJ, Kachur S, et al. Updates on obesity and the obesity paradox in cardiovascular diseases [J]. Prog Cardiovasc Dis, 2023, 7(8): 2-10.
[35]	Alebna P L, Mehta A, Yehya A, et al. Update on obesity, the obesity paradox, and obesity management in heart failure [J]. Prog Cardiovasc Dis, 2024, 9: S0033-0620(24)00003-3.
[36]	Bostrom JA, Mottel B, Heffron SP. Medical and Surgical Obesity Treatments and Atherosclerosis: Mechanisms beyond Typical Risk Factors [J]. Curr Atheroscler Rep, 2021, 23(10): 60.
[37]	彭荣刚, 张毅, 宛荣豪, 等. 肥胖症患者减重术后心脏结构功能变化及其机制的研究进展 [J]. 中国心血管杂志, 2020, 25(6): 588-590.
[38]	Lopez-Jimenez F, Almahmeed W, Bays H, et al. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation [J]. Eur J Prev Cardiol, 2022, 29(17): 2218-37.
[39]	Ahammed MR, Ananya FN. Impact of Weight Loss on Atrial Fibrillation [J]. Cureus, 2023, 15(9): e46232.
[40]	Blüher M, Aras M, Aronne LJ, et al. New insights into the treatment of obesity [J]. Diabetes Obes Metab, 2023, 25(8): 2058-2072.
[41]	Rieth AJ, Hamm CW, Wanner C, et al. [Heart failure protection by SGLT2 inhibitors in patients with type 2 diabetes mellitus: evidence and possible mechanisms: A systematic review [J]. Herz, 2021, 46(Suppl 2): 151-158.

排名	国家	发文量	中心性
1	美国	1740	0.11
2	英国	385	0.04
3	意大利	358	0.00
4	德国	351	0.04
5	加拿大	303	0.12
6	中国	294	0.00
7	日本	213	0.00
8	澳大利亚	206	0.04
9	荷兰	159	0.11
10	法国	147	0.11

排名	国家	发文量	中心性
1	美国	1740	0.11
2	英国	385	0.04
3	意大利	358	0.00
4	德国	351	0.04
5	加拿大	303	0.12
6	中国	294	0.00
7	日本	213	0.00
8	澳大利亚	206	0.04
9	荷兰	159	0.11
10	法国	147	0.11

排名	研究机构	发文量	中心性
1	哈佛大学	266	0.01
2	布列根和妇女医院	154	0.15
3	加州大学	148	0.02
4	哈佛医学院	147	0.00
5	杜克大学	131	0.04
6	梅奥医学中心	112	0.00
7	伦敦大学	105	0.04
8	美国退伍军人事务部	97	0.05
9	德克萨斯大学	96	0.04
10	退役军人医疗管理局	92	0.06

排名	研究机构	发文量	中心性
1	哈佛大学	266	0.01
2	布列根和妇女医院	154	0.15
3	加州大学	148	0.02
4	哈佛医学院	147	0.00
5	杜克大学	131	0.04
6	梅奥医学中心	112	0.00
7	伦敦大学	105	0.04
8	美国退伍军人事务部	97	0.05
9	德克萨斯大学	96	0.04
10	退役军人医疗管理局	92	0.06

聚类标签	轮廓值	关键词
减重	0.92	减重，舒张功能，T波形态，QRS间期，心衰
心衰	0.95	心衰，心肌重构，共焦显微镜，动脉硬化，心室重塑
房颤	0.94	心房颤动，心包脂肪，肿瘤恶病质，心功能，桥接
运动锻炼	0.95	运动锻炼，心血管疾病，心肺功能，肥胖悖论，内皮功能
先心病	0.86	先心病，心脏手术，重症监护，口服抗凝，定性分析
心血管疾病	0.95	心衰，房颤，心血管疾病，减重术，冠心病
BMI	0.98	身体质量指数，糖尿病，心血管疾病，危险因素，腰围
回顾性研究	0.91	心衰，回顾性研究，酰化肽，信息技术，心外膜脂肪
减重术	0.95	减重术，心衰,心血管疾病，房颤，心肌梗死
冠心病	0.95	心血管疾病，冠心病，减重术，心衰，静脉栓塞
减重	0.96	心衰，减重，质保协议，风险评估，充血性心衰
静脉栓塞	0.96	房颤，静脉栓塞，直接口服抗凝剂，低分子肝素，心脏再同步化治疗
血容量	0.90	心衰，血容量，氯化钠，钠钾氯共转运蛋白，30天再入院
系统评价	0.99	心衰，系统评价，序列分析，GLP-1受体激动剂，动态血压监测
动脉硬化	0.96	动脉硬化，血压，脉搏波传导速度，胰岛素抵抗，儿童肥胖
蛋白质百分比	0.96	减重，蛋白质百分比，右室功能不全，栓塞保护装置，主动脉瓣置换
心肌梗死	1	心肌梗死，心功能，心脏重塑，ACEI，β受体阻滞剂

Please choose a citation manager

Content to export